Prognostic factors in resected primary small bowel tumors

We report a retrospective analysis of 71 patients, operated for primary small bowel tumors (SET): 47 malignant (66.2%) and 24 benign (33.8%) tumors, Of the malignant tumors, adenocarcinomas predominated (38.3%), followed by neuroendocrine tumors (31.9%), Non-Hodgkin lymphomas (NHL) (12.8%), leiomyosarcomas (10.6%) and other rare entities (6.4%). Morbidity of surgical treatment was 16.9%, 30-day mortality 7%, The estimated 5-year survival rate is malignant lesions was 31.8%, Univariate analysis identified the presence of distant metastasis and the resection status (R status) as prognostic factors (p = 0.034 and p = 0.001.), There was no influence of T, N status or grading on survival, A complete macroscopic and microscopic tumor resection has to be the aim of ally curative surgical approach in patients with SET.